妊婦・授乳婦へのワクチン接種の有効性・安全性
SARS-CoV-2 Specific Antibodies in Breast Milk After COVID-19 Vaccination of Breastfeeding Women (Research Letter)
Perl SH, et al.〔JAMA. 2021 May 18;325(19):2013-2014〕(査読済み)
Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons
Shimabukuro TT, et al.〔N Engl J Med 2021 Jun 17; 384(24):2273-2282〕(査読済み)
Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women
Collier AY, et al.〔JAMA. 2021 Jun 15;325(23):2370-2380〕(査読済み)
Antibody Response to Coronavirus Disease 2019 (COVID-19) Messenger RNA Vaccination in Pregnant Women and Transplacental Passage Into Cord Blood (Research Letter)
Prabhu M, et al.〔Obstet Gynecol. 2021 Aug 1;138(2):278-280〕(査読済み)
Association Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women
Goldshtein I, et al.〔JAMA. 2021 Aug 24;326(8):728-735〕(査読済み)
Quantification of Specific Antibodies Against SARS-CoV-2 in Breast Milk of Lactating Women Vaccinated With an mRNA Vaccine (Research Letter)
Esteve-Palau E, et al.〔JAMA Netw Open. 2021 Aug 2;4(8):e2120575〕(査読済み)
COVID-19 Vaccination During Pregnancy: Coverage and Safety
Blakeway H, et al.〔Am J Obstet Gynecol. 2021 Aug 10;S0002-9378(21)00873-5〕(査読済み)
Short-term Reactions Among Pregnant and Lactating Individuals in the First Wave of the COVID-19 Vaccine Rollout (Research Letter)
Kachikis A, et al.〔JAMA Netw Open. 2021 Aug 2;4(8):e2121310〕(査読済み)
SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in Scotland
Stock SJ, et al.〔Nat Med. 2022 Jan 13〕(査読済み)
Durability of Anti-Spike Antibodies in Infants After Maternal COVID-19 Vaccination or Natural Infection (Research Letter)
Shook LL, et al.〔JAMA. 2022 Mar 15;327(11):1087-1089〕(査読済み)
規制機関情報
COVID-19 antivirals: reporting to the UK COVID-19 Antivirals Pregnancy Registry
〔英国 MHRA. Drug Safety Update, Volume 15, Issue 7, February 2022〕
Decreased milk supply during breastfeeding after COVID-19 vaccination
〔オランダLareb(Netherlands Pharmacovigilance Centre)〕